pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
CRISPR/Cas9 · news · pharmadog
← back to CRISPR/Cas9
News · CRISPR/Cas9
180
stories
Jul 24, 26
Scribe secures $129M in a rare gene editing IPO
biopharma dive
Jul 24, 26
Scribe records upsized $129M IPO to bankroll lipid-lowering genetic meds
fiercebiotech
Jul 22, 26
6 companies hiring in Cambridge now
biospace
Jul 20, 26
Scribe's $96M IPO; Scholar Rock awaits site classification for apitegromab
endpoints
Jul 20, 26
Genetic medicine luminaries launch new center for personalized therapies
fiercebiotech
Jul 20, 26
Scribe aims for $96M IPO to fund clinical push for lipid-lowering genetic meds
fiercebiotech
Jul 17, 26
STAT+: Can ultrasound unlock the power of gene therapy? A startup makes big claims
stat
Jul 15, 26
Nobel Laureate Jennifer Doudna enters AI protein design arena
fiercebiotech
Jul 13, 26
STAT+: Dementia study replicates promising outcomes following risk-reduction strategies
stat
Jul 13, 26
STAT+: All eyes on data on Biogen’s tau therapy
stat
Jul 13, 26
STAT+: A breakthrough in pancreatic cancer has experts excited — and braced for what’s to come
stat
Jul 12, 26
STAT+: Tau in the spotlight at Alzheimer’s conference
stat
Jul 10, 26
STAT+: Roche ends Huntington’s gene-silencing programs
stat
Jul 10, 26
ARPA-H puts $160M into bespoke drug therapies; Biohaven switches up scientific leadership
biopharma dive
Jul 10, 26
FDA quietly pushes back deadline on electric shock ban
stat
Jul 10, 26
New York boys club has a time-tested recipe to protect members’ mental health
stat
Jul 9, 26
ARPA-H bookmarks $160M for custom gene editing treatments. Is it enough?
endpoints
Jul 9, 26
Outbreak of diarrhea-causing parasite grows to more than 1,000 cases
stat
Jul 9, 26
STAT+: ARPA-H launches $160 million effort to develop custom gene editing drugs
stat
Jul 8, 26
Prime Medicine wins spat with Beam Therapeutics over AATD candidate
endpoints
Jul 8, 26
STAT+: Prime Medicine claims victory in dispute over gene-editing technology with Beam Therapeutics
stat
Jul 8, 26
Prime wins gene editing dispute; Saol claims latest post-Makary FDA reversal
biopharma dive
Jul 6, 26
Gene editing developer Scribe plots an IPO
biopharma dive
Jul 2, 26
Scribe Therapeutics files for IPO in test of appetite for early-stage biotechs
endpoints
Jul 2, 26
STAT+: A year after distressed buyout, what’s become of Bluebird Bio?
stat
Jul 1, 26
FDA Approves First Gene Therapy for Young Children with Sickle Cell Disease
fda press
Jul 1, 26
BridgeBio gets funding for drug launch; United buys into cell therapy
biopharma dive
Jun 29, 26
10 clinical trials to watch in the second half of 2026
biopharma dive
Jun 9, 26
Opinion: Ending animal testing could set back xenotransplantation just as the field is poised for a breakthrough
stat
Jun 4, 26
Scientists uncover a new hiding spot for HIV
stat
← prev
page 5 of 6
next →